2017
DOI: 10.1002/anie.201609557
|View full text |Cite
|
Sign up to set email alerts
|

An Efficient Chemoenzymatic Synthesis of Dihydroartemisinic Aldehyde

Abstract: Artemisinin from the plant Artemisia annua is the most potent pharmaceutical for the treatment of malaria. In the plant, the sesquiterpene cyclase amorphadiene synthase, a cytochrome‐dependent CYP450, and an aldehyde reductase convert farnesyl diphosphate (FDP) into dihydroartemisinic aldehyde (DHAAl), which is a key intermediate in the biosynthesis of artemisinin and a semisynthetic precursor for its chemical synthesis. Here, we report a chemoenzymatic process that is able to deliver DHAAl using only the sesq… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
39
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 53 publications
(44 citation statements)
references
References 53 publications
1
39
0
2
Order By: Relevance
“…For example,1 2-hydroxy-FPP was transformed by the amorphadiene synthase from Artemisia annua to yield the artemisinin precursor dihydroartemisinic aldehyde in 34 %y ield. [4] With the natural substrate 17,the yield could recently be raised to over 90 %u nder continuous flow conditions. [5] These few examples demonstrate that chemo-enzymatic use of TCs is an emerging field of research with prospects to access new terpene derivatives and even new terpenoid backbones.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…For example,1 2-hydroxy-FPP was transformed by the amorphadiene synthase from Artemisia annua to yield the artemisinin precursor dihydroartemisinic aldehyde in 34 %y ield. [4] With the natural substrate 17,the yield could recently be raised to over 90 %u nder continuous flow conditions. [5] These few examples demonstrate that chemo-enzymatic use of TCs is an emerging field of research with prospects to access new terpene derivatives and even new terpenoid backbones.…”
mentioning
confidence: 99%
“…Them ost remarkable product is the tricyclic cyclobuta- [3,4]cyclohepta[1,2-c]tetrahydrofuran derivative 25 obtained from ether 18.D espite the structural differences between presilphiperfolan-8-b-ol (9)a nd the derivative 25,asensible proposal for its formation is depicted in Scheme 3. The biosynthesis of 9 from FPP (17) [14] is initiated by formation of the humulyl cation 37.N ext, ac ationic cascade leads to cyclopentaindanyl cation 40 via cyclobutane 38 and bicyclic bridged cation 39,followed by athird cyclization.…”
mentioning
confidence: 99%
“…Recombinant AS and ADS were prepared and purified according to previously published procedures17,18 and both ( R )- 11 and ( S )- 11 were tested as inhibitors using a standard radiolabelled assay involving conversion of tritium labelled FDP by each enzyme and scintillation counting of the pentane extractable products 5 b . Terpene synthases are known to efficiently bind cation-PP i pairs and inhibition was assessed both in the presence and absence of 250 μM diphosphate (Table 1).…”
Section: Resultsmentioning
confidence: 99%
“… 14 As an example, it has been shown that ADS catalyses the cyclisation of 12-hydroxy FDP ( 6 ) to produce dihydroartemisinic aldehyde ( 7 ) ( Scheme 4 ) with a 34% yield. 12 The seemingly moderate yield is common for sesquiterpene cyclases as the reaction is limited by the release of the hydrocarbon products from the aqueous incubation media. 15 Aldehyde 7 is a well-established intermediate in the biosynthesis of artemisinin ( 1 ).…”
Section: Enzymatic Reactionmentioning
confidence: 99%
“…Amorphadiene synthase (ADS) is able to convert 6 in a single step to dihydroartemisinic aldehyde (DHAAl, 7 ), an advanced intermediate of artemisinin. 12 This route does not proceed via amorphadiene ( 3 ) and therefore avoids several redox steps. Increasing the oxidation state at the linear precursor stage produces a two-step synthesis of 4 , which significantly shortens the synthesis of artemisinin ( 1 ).…”
Section: Introductionmentioning
confidence: 99%